OVERVIEW

Targeted Protein Degradation (TPD) Europe Summit 2021 is organized by Hanson Wade. This Online CME Conference will be held from Mar 16 - 18, 2021.

Course Description:
The Targeted Protein Degradation Europe Summit is bound to deliver the high-quality insights and industry associations that our customers expect, in a format that is convenient from the comfort of your home or office.

With the ultimate goal of stimulating the translation of selective, bioavailable, and effective protein degraders into clinical trials, join TPD Europe to capitalize on this evolving therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.

Why You Should Attend:
• Explore the complete potential of protein degrader approaches to open up the therapeutic opportunity with insights from Brenda Schulman & Georg Winter
• Increase TPD strategies by uncovering novel E3 ligases with insights from AstraZeneca, Eli Lilly & PhoreMost
• Develop the horizon & impact of PROTACbased targeted degradation with insights from GSK, Bayer & Amphista Therapeutics
• Extend the horizon of targeted protein degradation beyond oncology and the UPS with insights from Goethe University Frankfurt & The Institute of Cancer Research
• Harness alternative next-generation platforms for inducing protein degradation with insights from Aelin Therapeutics & Mission Therapeutics

Workshops:
• WORKSHOP A - Tuesday 16th March 2021
Examining the Autophagy-Lysosomal Pathway to Discover Novel Targeted Protein Degradation Strategies

• WORKSHOP B - Tuesday 16th March 2021
Optimizing the Medicinal Chemistry of New Modalities

• WORKSHOP C - Tuesday 16th March 2021
Mathematical Knowledge of the Target Engagement or Ternary Complex Formation by the PROTAC or Molecular Glue Compounds and its Practical Implications

Course Objectives:
3 Benefits of Attending this Translational & Industry Dedicated Summit:
• Explore the next-generation of targets and therapeutic approaches beyond the ubiquitin-proteasome and oncology
• Examine the most advanced target validation and drug discovery strategies in the armory to identify novel TPD candidates
• Interact and network with the biggest experts in the field to discover the landscape beyond PROTAC-based strategies